The inability of chronic fluoxetine to potentiate a serotonin mediated effect.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism; D004347:Drug Interactions; D005473:Fluoxetine / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D011437:Propylamines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000502:physiology*
D011437:Propylamines; D005473:Fluoxetine; D015102:3,4-Dihydroxyphenylacetic Acid; D012701:Serotonin; D006220:Haloperidol; D006719:Homovanillic Acid